Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02227186 · ClinicalTrials.gov registry record · NA

Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York

A NA study of Childhood Influenza Vaccination and School-located Influenza Vaccination, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
20,461
Enrollment target
1
Study location

NCT02227186 is a NA study of Childhood Influenza Vaccination and School-located Influenza Vaccination that has completed, run by University of California, Los Angeles. The registered enrollment target is 20,461 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02227186, a NA study of Childhood Influenza Vaccination and School-located Influenza Vaccination, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
20,461 participants
Enrollment target
1
Study location

Study Summary

Children in schools in which influenza vaccination clinics are held during school hours will have higher rates of influenza vaccination than children in control schools (no school-located clinics offered)

Interventions

  • OTHER School-located Influenza Vaccination Clinic

Study Locations (1)

New York

  • University of Rochester School of Medicine and Dentistry - Rochester

Trial Details

FieldValue
Enrollment Target 20,461 participants
Start Date 2014-08-01
Est. Completion 2015-07-31
Phase NA

What the Registry Record Tells You About NCT02227186

The ClinicalTrials.gov registry entry for NCT02227186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20,461 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Childhood Influenza Vaccination appearing as the primary indexed condition, and to 1 intervention - of which School-located Influenza Vaccination Clinic is the first listed.

NCT02227186 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02227186 about?

NCT02227186 is a clinical study titled "Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York". Children in schools in which influenza vaccination clinics are held during school hours will have higher rates of influenza vaccination than children in control schools (no school-located clinics offered)

What is the current status of trial NCT02227186?

This trial is currently completed. It is a NA study. The enrollment target is 20,461 participants. The study started on 2014-08-01. Estimated completion is 2015-07-31.

What conditions does trial NCT02227186 study?

This clinical trial studies the following conditions: Childhood Influenza Vaccination, School-located Influenza Vaccination.

What interventions are being tested in trial NCT02227186?

The interventions under investigation include: School-located Influenza Vaccination Clinic (OTHER).

Who is sponsoring clinical trial NCT02227186?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02227186 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.